Pay in 4 interest-free payments of $5.10 Learn more
Ships within 48 hours · Estimated delivery Oct 10 - Oct 15
FDA's stated reasons: Immunogenicity risk Could trigger immune reactions Impurities Compounded versions may be contaminated Lack of characterization Don't fully understand the molecules No human safety data Haven't been properly tested Reported adverse events Some have documented side effects The DOJ Prosecution: $1.79 Million Forfeiture In a landmark case, the Department of Justice prosecuted Tailor Made Compounding LLC for distributing unapproved peptides including BPC-157
Regulatory Status of Peptide Compounding in 2025
doi:10.3390/ijms19071987 6
Similarly, compounds from the spiro-oxindole dihydroquinazolinone series identified in the screening, e.g., 42 are weak inhibitors and besides that not stable in in vitro assays
Accelerating Recovery: Animal studies have shown that BPC-157 can speed up healing, reduce recovery times, and improve functional outcomes after injuries
US$ 24.64
US$ 22.37
.png)
US$ 25.04
